nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—malignant glioma	0.774	1	CbGaD
Lucanthone—APEX1—fourth ventricle—malignant glioma	0.0631	0.546	CbGeAlD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—malignant glioma	0.00593	0.0545	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—malignant glioma	0.00593	0.0545	CbGpPWpGaD
Lucanthone—APEX1—MMR—MSH2—malignant glioma	0.00563	0.0518	CbGpPWpGaD
Lucanthone—APEX1—embryo—malignant glioma	0.0054	0.0467	CbGeAlD
Lucanthone—APEX1—brainstem—malignant glioma	0.00495	0.0428	CbGeAlD
Lucanthone—APEX1—retina—malignant glioma	0.00477	0.0413	CbGeAlD
Lucanthone—APEX1—telencephalon—malignant glioma	0.00439	0.038	CbGeAlD
Lucanthone—APEX1—medulla oblongata—malignant glioma	0.00345	0.0299	CbGeAlD
Lucanthone—TOP1—retina—malignant glioma	0.00334	0.0289	CbGeAlD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA2—malignant glioma	0.00331	0.0305	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ROS1—malignant glioma	0.00322	0.0296	CbGpPWpGaD
Lucanthone—APEX1—midbrain—malignant glioma	0.00315	0.0273	CbGeAlD
Lucanthone—APEX1—spinal cord—malignant glioma	0.00308	0.0266	CbGeAlD
Lucanthone—TOP1—telencephalon—malignant glioma	0.00307	0.0266	CbGeAlD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA2—malignant glioma	0.0026	0.0239	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MGMT—malignant glioma	0.00253	0.0233	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—FLT1—malignant glioma	0.0025	0.023	CbGpPWpGaD
Lucanthone—APEX1—central nervous system—malignant glioma	0.00249	0.0216	CbGeAlD
Lucanthone—APEX1—cerebellum—malignant glioma	0.00244	0.0211	CbGeAlD
Lucanthone—TOP1—medulla oblongata—malignant glioma	0.00241	0.0209	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFSF10—malignant glioma	0.00237	0.0218	CbGpPWpGaD
Lucanthone—TOP1—midbrain—malignant glioma	0.00221	0.0191	CbGeAlD
Lucanthone—TOP1—spinal cord—malignant glioma	0.00215	0.0186	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—NTRK3—malignant glioma	0.00201	0.0185	CbGpPWpGaD
Lucanthone—APEX1—brain—malignant glioma	0.00198	0.0172	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—BCAN—malignant glioma	0.00195	0.018	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—PTK2—malignant glioma	0.00179	0.0165	CbGpPWpGaD
Lucanthone—APEX1—Extension of Telomeres—TERT—malignant glioma	0.00179	0.0165	CbGpPWpGaD
Lucanthone—TOP1—cerebellum—malignant glioma	0.00171	0.0148	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00167	0.0154	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GDNF—malignant glioma	0.00157	0.0145	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—KDR—malignant glioma	0.00144	0.0133	CbGpPWpGaD
Lucanthone—TOP1—brain—malignant glioma	0.00139	0.012	CbGeAlD
Lucanthone—TOP2A—Gastric Cancer Network 1—H3F3A—malignant glioma	0.00137	0.0126	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GFAP—malignant glioma	0.00135	0.0125	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00127	0.0117	CbGpPWpGaD
Lucanthone—Cinchocaine—BCHE—malignant glioma	0.00124	0.659	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0012	0.0111	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LGALS3—malignant glioma	0.00118	0.0109	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MSH2—malignant glioma	0.00118	0.0108	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00107	0.00985	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2—malignant glioma	0.00104	0.00956	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PML—malignant glioma	0.00103	0.00946	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.00098	0.00901	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000979	0.00901	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TOP2A—malignant glioma	0.00094	0.00865	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP3—malignant glioma	0.000917	0.00843	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.000903	0.0083	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—malignant glioma	0.000859	0.0079	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—malignant glioma	0.000843	0.00775	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—TERT—malignant glioma	0.000811	0.00746	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TUBG2—malignant glioma	0.000807	0.00742	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	0.000794	0.00731	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GJA1—malignant glioma	0.000762	0.00701	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000762	0.00701	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—BRAF—malignant glioma	0.000734	0.00676	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NTRK1—malignant glioma	0.000731	0.00673	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—malignant glioma	0.000728	0.0067	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—NOTCH1—malignant glioma	0.000713	0.00656	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000708	0.00651	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000702	0.00646	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—APC—malignant glioma	0.000698	0.00642	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—malignant glioma	0.000679	0.00625	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—malignant glioma	0.000676	0.00622	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNF—malignant glioma	0.000667	0.00613	CbGpPWpGaD
Lucanthone—Procainamide—BCHE—malignant glioma	0.000644	0.341	CrCbGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—malignant glioma	0.000642	0.00591	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NCOR1—malignant glioma	0.000639	0.00588	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000638	0.00586	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NTRK3—malignant glioma	0.000627	0.00577	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RAF1—malignant glioma	0.000613	0.00564	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00057	0.00524	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000522	0.00481	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00051	0.00469	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—malignant glioma	0.000496	0.00457	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000494	0.00455	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000489	0.00449	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—malignant glioma	0.000485	0.00446	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—malignant glioma	0.000463	0.00426	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—malignant glioma	0.000458	0.00421	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—malignant glioma	0.00043	0.00395	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.000417	0.00384	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000416	0.00383	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000414	0.00381	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000411	0.00378	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000396	0.00364	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000395	0.00363	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000389	0.00358	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IFNG—malignant glioma	0.000389	0.00358	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000388	0.00357	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—malignant glioma	0.000385	0.00354	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000384	0.00353	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000375	0.00345	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000375	0.00345	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.000373	0.00343	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TUBG2—malignant glioma	0.000373	0.00343	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—malignant glioma	0.000373	0.00343	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PLK1—malignant glioma	0.000371	0.00341	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HIST1H3B—malignant glioma	0.000367	0.00338	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—malignant glioma	0.000365	0.00336	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—malignant glioma	0.000364	0.00335	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—malignant glioma	0.000361	0.00332	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—malignant glioma	0.000356	0.00327	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000348	0.0032	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL1B—malignant glioma	0.000347	0.00319	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—malignant glioma	0.000346	0.00318	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—malignant glioma	0.000345	0.00318	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000335	0.00308	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000327	0.00301	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—malignant glioma	0.000327	0.00301	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PML—malignant glioma	0.000321	0.00295	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.00032	0.00295	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000317	0.00292	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—malignant glioma	0.000314	0.00289	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000306	0.00281	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—malignant glioma	0.000299	0.00275	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—malignant glioma	0.000298	0.00274	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000296	0.00272	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000289	0.00266	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TOP2A—malignant glioma	0.000286	0.00263	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—H3F3A—malignant glioma	0.000284	0.00261	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—YWHAE—malignant glioma	0.000273	0.00251	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000272	0.0025	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—malignant glioma	0.00027	0.00248	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000266	0.00245	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—malignant glioma	0.000264	0.00243	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—malignant glioma	0.000261	0.0024	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000253	0.00233	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—malignant glioma	0.000252	0.00231	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000251	0.00231	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000238	0.00219	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000231	0.00212	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.00023	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	0.000228	0.0021	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000228	0.0021	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000227	0.00209	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000223	0.00205	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—malignant glioma	0.000222	0.00204	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000221	0.00203	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000219	0.00202	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—malignant glioma	0.000214	0.00197	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—malignant glioma	0.000207	0.0019	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2B—malignant glioma	0.000205	0.00189	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	0.0002	0.00184	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000199	0.00183	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000198	0.00182	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000192	0.00176	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.00019	0.00175	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000189	0.00174	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000178	0.00164	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—malignant glioma	0.000177	0.00163	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—malignant glioma	0.000172	0.00158	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PLK1—malignant glioma	0.000171	0.00158	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	0.00017	0.00156	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000166	0.00152	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000159	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000159	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000154	0.00142	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000153	0.0014	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000147	0.00135	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	0.000143	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000141	0.0013	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000131	0.00121	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—H3F3A—malignant glioma	0.000131	0.00121	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000131	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00013	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—YWHAE—malignant glioma	0.000126	0.00116	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000123	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000122	0.00112	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000121	0.00111	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00012	0.0011	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—malignant glioma	0.000117	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000117	0.00108	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—malignant glioma	0.000114	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000112	0.00103	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000109	0.001	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000106	0.000976	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000102	0.000941	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	9.82e-05	0.000903	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—malignant glioma	9.58e-05	0.000881	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2B—malignant glioma	9.49e-05	0.000873	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	9.24e-05	0.00085	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	9.16e-05	0.000843	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—malignant glioma	8.89e-05	0.000818	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	8.5e-05	0.000782	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	8.31e-05	0.000764	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BIRC5—malignant glioma	8.19e-05	0.000753	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—malignant glioma	7.95e-05	0.000732	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—malignant glioma	7.93e-05	0.00073	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.92e-05	0.000728	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	7.85e-05	0.000722	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	7.21e-05	0.000664	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.98e-05	0.000642	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—malignant glioma	6.7e-05	0.000616	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—malignant glioma	6.53e-05	0.000601	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	6.07e-05	0.000558	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.89e-05	0.000542	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—malignant glioma	5.43e-05	0.000499	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—malignant glioma	5.26e-05	0.000484	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	4.11e-05	0.000378	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—malignant glioma	3.68e-05	0.000338	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—malignant glioma	3.02e-05	0.000278	CbGpPWpGaD
